Sirius Therapeutics’ $50 Million Series B2 Financing Round

Leila Ahmed North America Legal Chronicle
Tagged:

Wilson Sonsini Goodrich & Rosati advised Sirius Therapeutics on patent matters related to the transaction.Biotechnology company Sirius Therapeutics (Sirius) announced that it has completed nearly $50…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here